Albus Pharmaceuticals Private Limited
Founded in 2003 and headquartered in Kerala, India.
2003 | Thrissur, Kerala (India) | Active
Albus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.95 M
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Albus Pharmaceuticals
Albus Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 November 2003 and has a history of 21 years and three months. Its registered office is in Thrissur, Kerala, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.95 M, as per Ministry of Corporate Affairs (MCA) records.
Latha Namboodiripad, Biju Namboodiri, and Rathibai Paragodan serve as directors at the Company.
Company Details
- Location
Thrissur, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232KL2003PTC016613
- Company No.
016613
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Nov 2003
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Trading
Who are the key members and board of directors at Albus Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Latha Namboodiripad  | Managing Director | 13-Nov-2003 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Biju Namboodiri | Director | 21-Mar-2012 | Current |
| Rathibai Paragodan | Whole-Time Director | 01-Nov-2016 | Current |
Financial Performance of Albus Pharmaceuticals.
Albus Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Albus Pharmaceuticals?
In 2017, Albus Pharmaceuticals had a promoter holding of 34.53% and a public holding of 65.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Chethana Remedies (India) Private Limited
Latha Namboodiripad is a mutual person
- Fling Pharmaceuticals Private Limited
Biju Namboodiri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Albus Pharmaceuticals?
Unlock and access historical data on people associated with Albus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Albus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Albus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
